Employees

Sven Gogov, MD, is an experienced global clinical development leader bringing over 15 years of pharmaceutical oncology experience and regulatory interactions to Nouscom. Sven joined Nouscom in [...]

Rick joined Nouscom in September 2020 from Johnson and Johnson Innovation where he was the Global Oncology Venture and Transaction Lead. He was Chief Executive Officer of a European clinical [...]

Göran has more than 35 years of leadership and management experience in the biotech and pharmaceutical industry, with Board positions at several global companies, including currently as Chairman [...]

Loredana recently joined Nouscom as the Technical Director from Reithera. She has fifteen years of industry experience spanning process development and GMP production of viral vectored vaccines. [...]

John has over 25 years of business development experience with some of the industry’s premier companies, including Genentech, Genzyme, Millennium Pharmaceuticals, MPM Capital, Biogen and [...]

Vincent has more than 25 years’ experience in the oncology and immunology field, including almost 15 years at GlaxoSmithKline (“GSK”) where he was Senior Vice-President and had responsibility for [...]

Jean-Paul served as a Senior Vice President of Research and Development at GlaxoSmithKline Biologicals (now GSK Vaccines) until January 2011. Jean-Paul joined GlaxoSmithKline Biologicals in 1987 [...]

Scott joined 5AM Ventures in 2003 as a Venture Partner and became a Managing Partner in 2004. He has over three decades of healthcare management experience with strategic leadership [...]

Genghis identifies and invests in new businesses and supports portfolio companies. He focuses on exits of venture investments via mergers and acquisitions and IPOs. Genghis’ current and past [...]

Joachim joined LSP in 2002 and is currently a Managing Partner and co-owner of the firm. His prime focus and responsibility within LSP is to invest in unlisted securities and the general [...]